The blog of Bill Gates
gatesnotes
The blog of Bill Gates

Eliminating Killer Diseases with New Medicines

Sign In
 
My Profile & Settings
Log out
GO
Your search for "", with selected filters, does not match any posts. Please try again with a different search term or reset filters.

Popular searches include: Books, Malaria, and Future of Food.
RELATED ARTICLES ON
Logout:


Become a Gates Notes Insider
- or - Sign up with email
This email is already registered. Enter a new email, try signing in or retrieve your password
Send me updates from Bill Gates
Sign Up
Join the Gates Notes community to access exclusive content, comment on stories, subscribe to your favorite topics and more. We will never share or spam your email address. For more information see our Sign Up FAQ. By clicking "Sign Up" you agree to the Gates Notes Terms of Use / Privacy Policy.
Account Settings
VIEW & EDIT PROFILE
Your Information
First name
Last name
Save
Cancel
Email address
This email is already registered
Save
Cancel
Please verify email address. Click verification link sent to this email address or resend verification email.
Password
Save
Cancel
Send me updates from Bill Gates
You must provide an email
Your Interests
Saving Lives
Energy Innovation
Improving Education
Philanthropy
Book Reviews
About Bill Gates
Deactivate Account
Click the link below to begin the account deactivation process. Deactivate account If you want to permanently delete your account and remove its content, please send us a request here.
Ok
Gates Notes Insider Sign Up FAQ

Q. How do I create a Gates Notes account?

A. There are three ways you can create a Gates Notes account:

  • Sign up with Facebook. We’ll never post to your Facebook account without your permission.
  • Sign up with Twitter. We’ll never post to your Twitter account without your permission.
  • Sign up with your email. Enter your email address during sign up. We’ll email you a link for verification.

Q. Will you ever post to my Facebook or Twitter accounts without my permission?

A. No, never.

Q. How do I sign up to receive email communications from my Gates Notes account?

A. In Account Settings, click the toggle switch next to “Send me updates from Bill Gates.”

Q. How will you use the Interests I select in Account Settings?

A. We will use them to choose the Suggested Reads that appear on your profile page.

Forgot your password?
This email is already registered. Enter a new email, try signing in or retrieve your password
Reset Password
Change your header photo
your image
 
Change
your image
Uh Oh!

The image you are trying to upload is either too big or is an unacceptable format. Please upload a .jpg or .png image that is under 25MB.

Ok
First name
Last name
Enter a first and last name. For example, "Richard Feynman"
Bio
0/160 characters
Edit Profile
Account Settings
Save
Cancel
Suggested Reads
Reset your password.
Set New Password
Your password has been reset. You will now be redirected to the sign in page, or you can click here
Ok
Get emails from Bill Gates
Send me updates from Bill
You must provide an email
This email is already registered
Continue
We will never share or spam your email address. For more information see our Sign Up FAQ. By clicking "Continue" you agree to the Gates Notes Terms of Use / Privacy Policy.
 
your image
Uh Oh!
The image you are trying to upload is either too big or is an unacceptable format. Please upload a .jpg or .png image that is under 25MB.
Ok
Welcome FirstName!
You are now a Gates Notes Insider
Update Your Profile Information
First name
Last name
Save
Cancel
Email address
This email is already registered
Save
Cancel
Please verify email address. Click verification link sent to this email address or resend verification email.
Send me updates from Bill Gates
You must provide an email
Select Your Interests
Saving Lives
Energy Innovation
Improving Education
Philanthropy
Book Reviews
About Bill Gates
Continue
Confirm
Are you sure you want to
deactivate your account?
Deactivating your account will unsubscribe you from Gates Notes emails, and will remove your profile and account information from public view on the Gates Notes. Please allow for 24 hours for the deactivation to fully process. You can sign back in at any time to reactivate your account and restore its content.
Deactivate My Acccount
Go Back
Your Gates Notes account has been deactivated.
Come back anytime.
Welcome back
In order to unsubscribe you will need to sign-in to your Gates Notes Insider account
Once signed in just go to your Account Settings page and set your subscription options as desired.
Sign In
Request account deletion
We’re sorry to see you go. Your request may take a few days to process; we want to double check things before hitting the big red button. Requesting an account deletion will permanently remove all of your profile content. If you’ve changed your mind about deleting your account, you can always hit cancel and deactivate instead.
Submit
Cancel
Thank You! Your request has been sent
Become a Gates Notes Insider for access to exclusive content and personalized reading suggestions
Sign up to receive occasional updates from the Gates Notes
Sign Up
Privacy Policy
Please complete your account verification. Resend verification email.
This verification token has expired.
Your email address has been verified. Update my profile.
Your account has been deactivated. Sign up to re-activate your account.
View all newsletters in the newsletter archive
You are now unsubscribed from receiving emails.
Sorry, we were unable to unsubscribe you at this time.
The blog of Bill Gates
Eliminating Killer Diseases with New Medicines
 
Hello, . . My Profile & Settings
Log out
FOLLOW ME
It looks like you're using an older version of Internet Explorer which may not display all the features on this site. Upgrade Now » close
Making Medicines Available

Eliminating Killer Diseases with New Medicines

In the developed world, we sometimes take life-saving medicines for granted. But as I’ve traveled in the developing world, I’ve seen first-hand the huge difference they can make. A new report and two recent announcements are reminders of the important role of the pharmaceutical industry, especially in helping save the lives of people in poor countries.

The new report is the Access to Medicine Index 2010 from the Access to Medicine Foundation, based in the Netherlands. The index ranks 20 of the world's largest pharmaceutical companies on their efforts to make sure that medicines are made for and reach people in developing countries. The latest index found that companies are being more transparent about their efforts to expand access. They’ve also taken steps to make drug pricing more equitable and to increase R&D on diseases affecting poor countries. But in the words of the Index’s founder Wim Leereveld, “the industry as a whole still has a long way to go.”

One example of progress on access is the announcement by GlaxoSmithKline and Pfizer Inc. that they will accelerate production and distribution of new vaccines against pneumococcal disease, which kills 1.6 million people a year—mostly in developing countries, and half of them children under the age of five.

Glaxo and Pfizer will supply 30 million doses a year, for 10 years, at a price that is more affordable for developing countries. Estimates are that the vaccines could save 900,000 lives by 2015, and up to 7 million lives by 2030. Key to this effort was an innovative financing mechanism, known as an Advance Market Commitment, piloted by the GAVI Alliance. I am pleased that our foundation was able to support this effort in partnership with GAVI, the World Bank, the World Health Organization, UNICEF and the national governments of Italy, Canada, Norway, Russia, and the United Kingdom.

In another important effort supported by the foundation, the non-profit Critical Path Institute (C-Path) and the Global Alliance for TB Drug Development (TB Alliance) will coordinate testing of promising combinations of tuberculosis drug candidates from at least 11 different pharmaceutical companies early in the development pipeline.

If you used the historical approach to testing and getting regulatory approval for new TB drugs—individually and then in combination with other drugs—it could take 24 years. This new approach, which the foundation created in partnership with C-Path and the TB Alliance, hopes to develop effective new combination TB treatments in just six years. Importantly, the U.S. Food and Drug Administration and regulatory authorities in Europe have indicated strong support for accelerating approvals of safe, effective new treatments.

Although many people think of TB as a disease that was conquered long ago, it still kills 1.8 million people a year, mainly in the poorest countries on earth. The current four-drug course of treatment for TB is now 50 years old and requires patients to take numerous pills for six months or longer, which many find difficult, especially given the often-unpleasant side effects. When patients don't complete their course of treatment, the disease can become resistant to the initial drugs. In 2007, there were more than 500,000 cases of drug-resistant TB. New and easier ways to treat TB would be a great step forward.

I believe that these kinds of innovative collaborations between pharmaceutical companies, governments and the non-profit sector are critical to accelerating the delivery of medicines, which is critical to saving lives.

Become a Gates Notes Insider for access to exclusive content and personalized reading suggestions

Read previous versions of the Annual Letter


Discussion
comments powered by Disqus